Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dau-Ming Niu

Showing results (111-120 of 184) with videos related to

Pageof 19
Sort By:
European Journal of Clinical Investigation|November 6, 2025
Long-term effectiveness and safety outcomes in adults with Fabry disease treated with agalsidase alfa: 20 years of data from the Fabry Outcome SurveyDerralynn A Hughes, Guillem Pintos-Morell, Christoph Kampmann, et al.
Orphanet Journal of Rare Diseases|February 12, 2014
Natural history and clinical assessment of Taiwanese patients with mucopolysaccharidosis IVAHsiang-Yu Lin, Chih-Kuang Chuang, Ming-Ren Chen, et al.
Molecular Genetics & Genomic Medicine|October 9, 2018
The relationships between urinary glycosaminoglycan levels and phenotypes of mucopolysaccharidosesHsiang-Yu Lin, Chung-Lin Lee, Yun-Ting Lo, et al.
The Canadian Journal of Cardiology|March 9, 2025
Early Potentially Irreversible Cardiac Damage in Fabry Disease Precedes Gb3 Inclusion Body FormationChung-Lin Lee, Pei-Sin Chen, Yu-Ying Lu, et al.
Pediatric Pulmonology|August 19, 2010
Polysomnographic characteristics in patients with mucopolysaccharidosesHsiang-Yu Lin, Ming-Ren Chen, Ching-Chi Lin, et al.
Gene Therapy|April 18, 2026
Beneficial bystander-enhanced cryptic splice rescue of cardiac-type Fabry GLA IVS4+919G>A by adenine base editing in patient fibroblastsHua-Chuan Chao, Yu-Ying Lu, Yu-Ting Chiang, et al.
Molecular Genetics and Metabolism Reports|April 25, 2025
Two decades of experience of the Fabry Outcome Survey provides further confirmation of the long-term effectiveness of agalsidase alfa enzyme replacement therapyUma Ramaswami, Guillem Pintos-Morell, Christoph Kampmann, et al.
World Journal of Surgery|September 16, 2011
Comparison of the survival difference between AJCC 6th and 7th editions for gastric cancer patientsWen-Liang Fang, Kuo-Hung Huang, Jen-Hao Chen, et al.
Investigative Ophthalmology & Visual Science|July 9, 2016
Homozygosity Mapping and Whole-Genome Sequencing Links a Missense Mutation in POMGNT1 to Autosomal Recessive Retinitis PigmentosaNana Hsiang-Hua Wang, Shih-Jen Chen, Chi-Fan Yang, et al.
Journal of Inherited Metabolic Disease|June 4, 2010
Clinical observations, molecular genetic analysis, and treatment of sitosterolemia in infants and childrenDau-Ming Niu, Kah-Wai Chong, Ju-Hui Hsu, et al.
Pageof 19

Showing results (111-120 of 184) with videos related to

Sort By:
Pageof 19
European Journal of Clinical Investigation|November 6, 2025
Long-term effectiveness and safety outcomes in adults with Fabry disease treated with agalsidase alfa: 20 years of data from the Fabry Outcome SurveyDerralynn A Hughes, Guillem Pintos-Morell, Christoph Kampmann, et al.
Orphanet Journal of Rare Diseases|February 12, 2014
Natural history and clinical assessment of Taiwanese patients with mucopolysaccharidosis IVAHsiang-Yu Lin, Chih-Kuang Chuang, Ming-Ren Chen, et al.
Molecular Genetics & Genomic Medicine|October 9, 2018
The relationships between urinary glycosaminoglycan levels and phenotypes of mucopolysaccharidosesHsiang-Yu Lin, Chung-Lin Lee, Yun-Ting Lo, et al.
The Canadian Journal of Cardiology|March 9, 2025
Early Potentially Irreversible Cardiac Damage in Fabry Disease Precedes Gb3 Inclusion Body FormationChung-Lin Lee, Pei-Sin Chen, Yu-Ying Lu, et al.
Pediatric Pulmonology|August 19, 2010
Polysomnographic characteristics in patients with mucopolysaccharidosesHsiang-Yu Lin, Ming-Ren Chen, Ching-Chi Lin, et al.
Gene Therapy|April 18, 2026
Beneficial bystander-enhanced cryptic splice rescue of cardiac-type Fabry GLA IVS4+919G>A by adenine base editing in patient fibroblastsHua-Chuan Chao, Yu-Ying Lu, Yu-Ting Chiang, et al.
Molecular Genetics and Metabolism Reports|April 25, 2025
Two decades of experience of the Fabry Outcome Survey provides further confirmation of the long-term effectiveness of agalsidase alfa enzyme replacement therapyUma Ramaswami, Guillem Pintos-Morell, Christoph Kampmann, et al.
World Journal of Surgery|September 16, 2011
Comparison of the survival difference between AJCC 6th and 7th editions for gastric cancer patientsWen-Liang Fang, Kuo-Hung Huang, Jen-Hao Chen, et al.
Investigative Ophthalmology & Visual Science|July 9, 2016
Homozygosity Mapping and Whole-Genome Sequencing Links a Missense Mutation in POMGNT1 to Autosomal Recessive Retinitis PigmentosaNana Hsiang-Hua Wang, Shih-Jen Chen, Chi-Fan Yang, et al.
Journal of Inherited Metabolic Disease|June 4, 2010
Clinical observations, molecular genetic analysis, and treatment of sitosterolemia in infants and childrenDau-Ming Niu, Kah-Wai Chong, Ju-Hui Hsu, et al.
Pageof 19